Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation.

Standard

Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation. / Mayr, Georg W.; Reed, M; Wang, P; Wang, Y; Schweds, J F; Tegtmeyer, P.

in: CANCER RES, Jahrgang 55, Nr. 11, 11, 1995, S. 2410-2417.

Publikationen: SCORING: Beitrag in Fachzeitschrift/ZeitungSCORING: ZeitschriftenaufsatzForschungBegutachtung

Harvard

Mayr, GW, Reed, M, Wang, P, Wang, Y, Schweds, JF & Tegtmeyer, P 1995, 'Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation.', CANCER RES, Jg. 55, Nr. 11, 11, S. 2410-2417. <http://www.ncbi.nlm.nih.gov/pubmed/7757994?dopt=Citation>

APA

Mayr, G. W., Reed, M., Wang, P., Wang, Y., Schweds, J. F., & Tegtmeyer, P. (1995). Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation. CANCER RES, 55(11), 2410-2417. [11]. http://www.ncbi.nlm.nih.gov/pubmed/7757994?dopt=Citation

Vancouver

Mayr GW, Reed M, Wang P, Wang Y, Schweds JF, Tegtmeyer P. Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation. CANCER RES. 1995;55(11):2410-2417. 11.

Bibtex

@article{18343989869148049f626145c912a4d8,
title = "Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation.",
abstract = "Murine tumor suppressor p53 is phosphorylated in the NH2-terminal transactivating domain at serines 9, 18, and 37. Change of any one of these serines to either alanine or aspartic acid did not alter p53 suppression of transformation of rat embryo fibroblasts by activated ras and E1A. Change of any two of these serines to alanines, however, led to a significant decrease in suppressor function. Substitution of alanines for all three serines caused the most severe loss of suppression and also reduced transactivation functions. The triple substitution had no apparent effects on intracellular accumulation or localization of p53, oligomerization, DNA binding, or interaction with the TFIID TATA-binding protein. In contrast, triple substitution of aspartic acid for serines 9, 18, and 37 had minimal effects on suppression and transactivation by p53. These results argue strongly that phosphorylation of serines 9, 18, and 37 facilitates the suppression and transactivation functions of p53.",
author = "Mayr, {Georg W.} and M Reed and P Wang and Y Wang and Schweds, {J F} and P Tegtmeyer",
year = "1995",
language = "Deutsch",
volume = "55",
pages = "2410--2417",
journal = "CANCER RES",
issn = "0008-5472",
publisher = "American Association for Cancer Research Inc.",
number = "11",

}

RIS

TY - JOUR

T1 - Serine phosphorylation in the NH2 terminus of p53 facilitates transactivation.

AU - Mayr, Georg W.

AU - Reed, M

AU - Wang, P

AU - Wang, Y

AU - Schweds, J F

AU - Tegtmeyer, P

PY - 1995

Y1 - 1995

N2 - Murine tumor suppressor p53 is phosphorylated in the NH2-terminal transactivating domain at serines 9, 18, and 37. Change of any one of these serines to either alanine or aspartic acid did not alter p53 suppression of transformation of rat embryo fibroblasts by activated ras and E1A. Change of any two of these serines to alanines, however, led to a significant decrease in suppressor function. Substitution of alanines for all three serines caused the most severe loss of suppression and also reduced transactivation functions. The triple substitution had no apparent effects on intracellular accumulation or localization of p53, oligomerization, DNA binding, or interaction with the TFIID TATA-binding protein. In contrast, triple substitution of aspartic acid for serines 9, 18, and 37 had minimal effects on suppression and transactivation by p53. These results argue strongly that phosphorylation of serines 9, 18, and 37 facilitates the suppression and transactivation functions of p53.

AB - Murine tumor suppressor p53 is phosphorylated in the NH2-terminal transactivating domain at serines 9, 18, and 37. Change of any one of these serines to either alanine or aspartic acid did not alter p53 suppression of transformation of rat embryo fibroblasts by activated ras and E1A. Change of any two of these serines to alanines, however, led to a significant decrease in suppressor function. Substitution of alanines for all three serines caused the most severe loss of suppression and also reduced transactivation functions. The triple substitution had no apparent effects on intracellular accumulation or localization of p53, oligomerization, DNA binding, or interaction with the TFIID TATA-binding protein. In contrast, triple substitution of aspartic acid for serines 9, 18, and 37 had minimal effects on suppression and transactivation by p53. These results argue strongly that phosphorylation of serines 9, 18, and 37 facilitates the suppression and transactivation functions of p53.

M3 - SCORING: Zeitschriftenaufsatz

VL - 55

SP - 2410

EP - 2417

JO - CANCER RES

JF - CANCER RES

SN - 0008-5472

IS - 11

M1 - 11

ER -